Genomic analysis of early spread of monkeypox virus in Washington State

Competing Interest Statement

A.L.G. reports central contract testing for Abbott, Cepheid, Hologic, Pfizer, Novavax, Janssen and research support from Gilead unrelated to this work.

Funding Statement

Supported by NIH AI027757 (P.R.). Computational analyses were supported by Fred Hutch Scientific Computing (NIH Office of Research Infrastructure Programs grant S10OD028685) and University of Washington Laboratory Medicine Informatics.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of University of Washington gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes